基于“伏瘀理论”治疗银屑病
Treatment of Psoriasis Based on the “Theory of Latent Stasis”
DOI: 10.12677/acm.2025.15113091, PDF,   
作者: 雷晶晶:云南中医药大学第一临床医学院,云南 昆明;雷志强:豫北医学院智行书院,河南 新乡;叶建州*:云南省中医医院皮肤科,云南 昆明
关键词: 银屑病伏瘀理论中医药Psoriasis The Theory of Latent Stasis Traditional Chinese Medicine
摘要: 银屑病又称民间俗称的“牛皮癣”,是一种较为普遍且易复发的顽疾。是由环境和遗传因素共同影响其发病的一种慢性、炎症性、复发性、系统性免疫介导疾病。其典型临床表现是皮肤上红斑、丘疹、鳞屑损害。这些症状给病人带来生理上的痛苦,给病人的心理健康造成不良影响。这种疾病可能导致患者产生自卑感,影响他们的社交活动和人际关系,进一步影响患者的生活质量。其确切的病因仍未完全明确,随着科技进步,人们对于银屑病的理解越来越深入,但是现有的治疗方法仍难以根治此病。因此,研究银屑病的发病机制,以及银屑病的转归特点,和预后康复情况是极其重要的,这可以帮助我们寻找更有效的治疗方法。
Abstract: Psoriasis, also known as “Niupixuan” among the people, is a common and recurrent chronic disease. It is a chronic, inflammatory, recurrent and systemic immune-mediated disease affected by environmental and genetic factors. Its typical clinical manifestations are erythema, papules and scale damage on the skin. These symptoms bring physical pain to patients and have adverse effects on their mental health. This disease may cause patients to feel inferior, affect their social activities and interpersonal relationships, and further affect the quality of life of patients. The exact cause of psoriasis is still not completely clear. With the progress of science and technology, people have a deeper understanding of psoriasis, but the existing treatment methods are still difficult to eradicate the disease. Therefore, it is extremely important to study the pathogenesis of psoriasis, as well as the characteristics of psoriasis’s prognosis and rehabilitation, which can help us find more effective treatment methods.
文章引用:雷晶晶, 雷志强, 叶建州. 基于“伏瘀理论”治疗银屑病[J]. 临床医学进展, 2025, 15(11): 248-252. https://doi.org/10.12677/acm.2025.15113091

参考文献

[1] Rendon, A. and Schäkel, K. (2019) Psoriasis Pathogenesis and Treatment. International Journal of Molecular Sciences, 20, Article 1475. [Google Scholar] [CrossRef] [PubMed]
[2] 晋红中, 唐珂韵. 炎症性皮肤病——传统与现代: 疾病概念、发病机制、治疗方法的演变历程[J]. 中华临床免疫和变态反应杂志, 2024, 18(4): 335-342.
[3] 张学军, 郑捷. 皮肤性病学[M]. 第9版. 北京: 人民卫生出版社, 2018: 133.
[4] Armstrong, A.W. and Read, C. (2020) Pathophysiology, Clinical Presentation, and Treatment of Psoriasis. JAMA, 323, 1945-1960. [Google Scholar] [CrossRef] [PubMed]
[5] 史玉玲. 《中国银屑病诊疗指南(2023版)》解读[J]. 同济大学学报(医学版), 2023, 44(5): 631-633.
[6] Ryan, G.E., Harris, J.E. and Richmond, J.M. (2021) Resident Memory T Cells in Autoimmune Skin Diseases. Frontiers in Immunology, 12, Article 652191. [Google Scholar] [CrossRef] [PubMed]
[7] Tokura, Y., Phadungsaksawasdi, P., Kurihara, K., Fujiyama, T. and Honda, T. (2021) Pathophysiology of Skin Resident Memory T Cells. Frontiers in Immunology, 11, Article 618897. [Google Scholar] [CrossRef] [PubMed]
[8] Ma, F., Plazyo, O., Billi, A.C., Tsoi, L.C., Xing, X., Wasikowski, R., et al. (2023) Single Cell and Spatial Sequencing Define Processes by Which Keratinocytes and Fibroblasts Amplify Inflammatory Responses in Psoriasis. Nature Communications, 14, Article No. 3455. [Google Scholar] [CrossRef] [PubMed]
[9] 聂红明, 董慧琳, 高月求, 等. 从“伏邪学说”论述慢性乙型肝炎从肾论治的理论渊源[J]. 中医杂志, 2012, 53(7): 541-543.
[10] 李煜, 林鹏, 王红梅. 王红梅基于伏邪温病论治银屑病[J]. 中国中医基础医学杂志, 2020, 26(11): 1723-1725.
[11] 张雪珥, 庞尧斌, 王栩芮, 等. 艾儒棣运用“伏瘀”理论治疗慢性荨麻疹复发经验[J]. 中医杂志, 2022, 63(12): 1113-1117.
[12] 周洁良. 基于伏瘀理论治疗复发性口腔溃疡验案一则[J]. 中国乡村医药, 2024, 31(1): 28-29.
[13] Nestle, F.O., Kaplan, D.H. and Barker, J. (2009) Psoriasis. New England Journal of Medicine, 361, 496-509. [Google Scholar] [CrossRef] [PubMed]
[14] Kurihara, K., Fujiyama, T., Phadungsaksawasdi, P., Ito, T. and Tokura, Y. (2019) Significance of Il-17a-Producing CD8+CD103+ Skin Resident Memory T Cells in Psoriasis Lesion and Their Possible Relationship to Clinical Course. Journal of Dermatological Science, 95, 21-27. [Google Scholar] [CrossRef] [PubMed]
[15] Chen, L. and Shen, Z. (2019) Tissue-resident Memory T Cells and Their Biological Characteristics in the Recurrence of Inflammatory Skin Disorders. Cellular & Molecular Immunology, 17, 64-75. [Google Scholar] [CrossRef] [PubMed]
[16] 秦万章. 血热证理论在皮肤科中的应用研究[J]. 中国中西医结合皮肤性病学杂志, 2015, 14(4): 205-214.
[17] 马晓宇, 杨帆, 何佳明. 基于《黄帝内经》营卫理论探讨银屑病的发生发展[J]. 天津中医药大学学报, 2024, 43(2): 176-180.
[18] 廖承成, 赵丽娟, 杨瑾, 等. 刘复兴教授治疗银屑病经验举隅[J]. 云南中医学院学报, 2016, 39(2): 88-89, 94.
[19] 王丹阳, 冯毅晖, 潘加豪, 等. 黄芪的主要化学成分及药理作用[J]. 新民, 2024(24): 126-128.
[20] 程馨玮, 高萍. 基于自噬调控的黄芪药理作用研究进展[J]. 中成药, 2024, 46(1): 198-203.
[21] 吴娇, 仝芳超. 黄芪的化学成分、药理作用及临床应用[J]. 滨州医学院学报, 2024, 47(1): 68-75.
[22] 周玉媛, 周萌, 王起成, 等. 赤芍在银屑病各型血证中的临床应用及现代药理研究[J]. 西部中医药, 2022, 35(8): 150-153.
[23] 梁莉, 鲁佑瑜, 劳小平, 等. 黄芪甲苷通过PPARγ抑制Th1、Th17分化改善自身免疫性脑脊髓炎[J]. 免疫学杂志, 2021, 37(11): 954-961.
[24] 黄武祯, 陈斯宁, 黎展华. 黄芪活性成分调控Th17/Treg细胞免疫平衡作用的研究进展[J]. 中华医院感染学杂志, 2024, 34(22): 3515-3520.